Wells Fargo analyst Mohit Bansal assigned a Buy rating on Eli Lilly & Co (LLY – Research Report) yesterday and set a price target of ...

In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Eli Lilly & Co (LLY – ...

Eli Lilly (LLY) partners with Genetic Leap to develop gene-based therapeutics using AI-driven drug discovery, in a deal worth ...

Jim Cramer’s 10 Best Stock Picks for Investors Right Now. In this article, we are going to take a look at where Eli Lilly and ...

Eli Lilly surged 58% in 2024, driven by weight-loss drugs and strong earnings. The technical chart shows consolidation. See ...

We recently compiled a list of the 10 Best Counter Cyclical and Defensive Stocks to Invest In. In this article, we are going ...

Since 2021, EVA Pharma has been working with Lilly to ensure a sustainable supply of life-saving medicines across several ...

Eli Lilly's experimental next generation weight-loss drug mimics three hormones instead of just one or two and continues to ...

The financial leadership transition is coming as the pharma giant hovers just below a $1 trillion market cap in the midst of rising demand for several new medications.

Eli Lilly’s experimental insulin that is injected just once a week is as effective as daily insulin injections for ...

Pharmaceutical companies must prioritize efforts to reach patients in underserved parts of the world with medicines such as insulin for diabetics and, crucially, measure the effectiveness of these ...

As the company continues to push for GLP-1 market share, it has tapped an internal veteran with recent experience managing research and development finance.